Novan, Inc. Banner Image

Novan, Inc.

  • Ticker NOVN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Novan, Inc. Logo Image
  • 11-50 Employees
  • Based in Morrisville, North Carolina
Novan, Inc. is a clinical development-stage biotechnology company focused on leveraging its proprietary nitric oxide (NO) based technology platform, NITRICIL™ to generate macromolecular New Chemical Entities (NCEs) to treat multiple indications in dermatology, men’s and women’s health, infectious diseases and gastroenterology conditions with significant unmet needs. The Company’s lead productMore candidate, SB206, a topical antiviral gel, for the treatment of molluscum contagiosum, is currently being evaluated in the B-SIMPLE4 pivotal Phase 3 clinical study. The Company believes that SB206 as a topical, at-home, caregiver-applied therapy with a rapid treatment benefit, if approved, would address an important patient-care need for the treatment of molluscum.
4.8 / 5.0 (242)

Novan, Inc. reports have an aggregate usefulness score of 4.8 based on 242 reviews.

Novan, Inc.

Most Recent Annual Report

Novan, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Novan, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!